Compare ZVRA & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | JBGS |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.9M | 823.7M |
| IPO Year | 2015 | 2017 |
| Metric | ZVRA | JBGS |
|---|---|---|
| Price | $13.16 | $14.61 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $23.00 | $15.00 |
| AVG Volume (30 Days) | ★ 1.5M | 608.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | ★ 159.21 | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | $106,470,000.00 | ★ $498,598,000.00 |
| Revenue This Year | $37.27 | N/A |
| Revenue Next Year | $53.42 | N/A |
| P/E Ratio | $21.88 | ★ N/A |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $13.71 |
| 52 Week High | $15.04 | $24.30 |
| Indicator | ZVRA | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 48.92 |
| Support Level | $8.26 | $14.09 |
| Resistance Level | $14.27 | $15.42 |
| Average True Range (ATR) | 0.67 | 0.45 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 13.65 | 33.12 |
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.